Knight Therapeutics Inc.
KHTRF
$6.59
$0.111.70%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.64% | -236.11% | 88.13% | 100.84% | 161.52% |
| Total Depreciation and Amortization | 17.92% | 4.64% | 6.88% | -2.61% | 1.27% |
| Total Amortization of Deferred Charges | 6.37% | 6.37% | 2.25% | 2.25% | 2.25% |
| Total Other Non-Cash Items | 339.92% | 1,439.11% | -83.65% | -97.53% | -126.11% |
| Change in Net Operating Assets | 146.19% | 111.19% | -1,026.22% | -1,307.94% | -2,070.03% |
| Cash from Operations | 1,075.45% | 84.76% | -34.26% | -52.96% | -85.98% |
| Capital Expenditure | -143.56% | 26.08% | 20.79% | 17.21% | -11.87% |
| Sale of Property, Plant, and Equipment | -100.00% | -82.08% | -93.68% | -93.68% | -93.51% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -75.61% | 89.66% | 2,083.28% | 206.87% | 429.12% |
| Cash from Investing | -233.76% | -564.83% | -1,503.38% | -286.87% | 407.25% |
| Total Debt Issued | 2,227.65% | 3,126.89% | 3,713.86% | 2,736.02% | 0.92% |
| Total Debt Repaid | -377.64% | -334.14% | -178.97% | -167.99% | 9.68% |
| Issuance of Common Stock | -29.56% | -26.55% | -22.36% | 78.39% | 187.85% |
| Repurchase of Common Stock | 7.92% | 28.36% | 62.71% | 63.61% | 71.51% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.42% | 0.28% | 18.73% | 27.04% | 28.39% |
| Cash from Financing | 69.13% | 117.28% | 145.97% | 143.49% | 52.22% |
| Foreign Exchange rate Adjustments | -200.49% | -278.19% | -60.26% | -3,045.88% | -14.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.72% | -122.05% | 286.41% | -33.40% | 579.22% |